Authors
Saleh Ramezani, Niki M Zacharias, William Norton, Jennifer S Davis, Abishai Dominic, Ryan Armijo, Muxin Wang, Richard E Wendt Iii, Daniel D Carson, Daniel A Harrington, Mary C Farach-Carson, Pratip K Bhattacharya
Published in
Advanced healthcare materials. Nov 14, 2026. Epub Nov 14, 2026.
Abstract
Visualization of colorectal cancer (CRC) lesions is complicated by their location in the colon and tumor morphology. Reliance on a single surface biomarker for direct identification risks false negatives due to temporal changes and/or tumor heterogeneity. We developed a multiplexed system of complementary biomarker targets to capture a broader range of lesions with diverse temporal and/or phenotypic expression. We identified Mucin-1 (MUC1) and epithelial cell adhesion molecule (EPCAM) as useful targeting pairs by phenotyping CRC subtypes in a standard tissue array and surveying CRC cell lines in 2D and 3D formats to confirm expression of these surface biomarkers. Through a "universal" approach using Antibody-Protein L Microparticles (APL-MPs), we functionalized microparticle surfaces with antibodies recognizing either MUC1 or EPCAM. We generated heterogeneous CRC tumoroids and orthotopic animal models, expressing both MUC1 and EPCAM, and demonstrated that: (1) APL-MPs identified MUC1- and EPCAM-positive tumoroids in proportion to antigen expression; (2) APL-MPs detected CRC surface antigens on the luminal colon surface in vivo, and (3) concurrent targeting of multiple surface antigens enhanced detection sensitivity for heterogeneous CRC lesions. This approach supports broader applications of APL-MPs for detecting heterogeneous cancer lesions and offers a promising strategy for accurate tumor visualization in complex environments.
PMID:
43034275
Bibliographic data and abstract were imported from PubMed on 15 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 5
- Comments 0